{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:53:52Z","timestamp":1776088432020,"version":"3.50.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) South London","award":["12951-20"],"award-info":[{"award-number":["12951-20"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Rapid antimicrobial susceptibility testing (rAST) has the potential to improve care of bloodstream infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim of this service evaluation was to assess the impact of rAST on antimicrobial therapy and clinical outcomes in patients with Gram-negative bloodstream infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective service evaluation was conducted from March 2018 to December 2018. A rAST system (Alfred 60AST) was run Monday\u2013Friday before midday and results were communicated to clinicians on the same day as positive blood culture, with subsequent conventional AST performed. Times to antibiotic therapy and clinical outcomes were compared between rAST and conventional AST.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>One hundred and ninety-one patients with Gram-negative bacteraemia were included (93 in the rapid group and 98 in the conventional group). Aminoglycoside combination therapy was stopped earlier in the rapid group [32 h (0\u2013795) versus 54 h (4\u2013216), P = 0.002]. The median time to optimal antibiotic based on AST results was significantly shorter than that in the conventional group [50 h (10\u2013339) versus 69.5 h (20\u2013872), P = 0.034]. In the subgroup of patients on ineffective empirical antibiotic, time to effective antibiotic was shorter in the rapid group [39.5 h (32\u201397) versus 57 h (49\u201383), P = 0.036]. No differences were found in 28 day mortality or length of stay.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Rapid susceptibility testing resulted in faster discontinuation of aminoglycosides and a shorter time to starting effective and optimal antibiotic when compared with conventional AST results. rAST has potential clinical benefits and points to the need for larger future studies in areas of high antibiotic resistance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkab449","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T12:06:49Z","timestamp":1637582809000},"page":"771-781","source":"Crossref","is-referenced-by-count":22,"title":["Impact of rapid susceptibility testing on antimicrobial therapy and clinical outcomes in Gram-negative bloodstream infections"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-3017","authenticated-orcid":false,"given":"Vanesa","family":"Anton-Vazquez","sequence":"first","affiliation":[{"name":"Institute of Infection and Immunity, St George\u2019s University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Suarez","sequence":"additional","affiliation":[{"name":"Institute of Infection and Immunity, St George\u2019s University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Planche","sequence":"additional","affiliation":[{"name":"Institute of Infection and Immunity, St George\u2019s University of London, London, UK"},{"name":"Department of Medical Microbiology, Southwest London Pathology, St George\u2019s Hospital, London, UK"},{"name":"Infection Care Group, St George\u2019s University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"2022022313004078000_dkab449-B1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"2022022313004078000_dkab449-B2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N Engl J Med"},{"key":"2022022313004078000_dkab449-B3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2022022313004078000_dkab449-B4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/CCM.0000000000002184","article-title":"Survival benefit and cost savings from compliance with a simplified 3-hour sepsis bundle in a series of prospective, multisite, observational cohorts","volume":"45","author":"Leisman","year":"2017","journal-title":"Crit Care Med"},{"key":"2022022313004078000_dkab449-B5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"2022022313004078000_dkab449-B6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","article-title":"Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program","volume":"42","author":"Ferrer","year":"2014","journal-title":"Crit Care Med"},{"key":"2022022313004078000_dkab449-B7","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/AAC.00466-06","article-title":"Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay","volume":"50","author":"Scarsi","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2022022313004078000_dkab449-B8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/dkm279","article-title":"Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia","volume":"60","author":"Peralta","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2022022313004078000_dkab449-B9","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1097\/CCM.0000000000000516","article-title":"Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock","volume":"42","author":"Vazquez-Guillamet","year":"2014","journal-title":"Crit Care Med"},{"key":"2022022313004078000_dkab449-B10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jinf.2014.09.002","article-title":"Clinical characteristics and outcome of elderly patients with community-onset bacteremia","volume":"70","author":"Hernandez","year":"2015","journal-title":"J Infect"},{"key":"2022022313004078000_dkab449-B11","volume-title":"Blood Cultures IV","author":"Baron","year":"2005"},{"key":"2022022313004078000_dkab449-B12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"key":"2022022313004078000_dkab449-B13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41579-020-0327-x","article-title":"Innovative and rapid antimicrobial susceptibility testing systems","volume":"18","author":"van Belkum","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"2022022313004078000_dkab449-B14","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/JCM.00712-14","article-title":"The value of outcomes data in the practice of clinical microbiology","volume":"52","author":"Doern","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2022022313004078000_dkab449-B15","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1093\/jac\/dkaa333","article-title":"EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories","volume":"75","author":"\u00c5kerlund","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2022022313004078000_dkab449-B16","doi-asserted-by":"crossref","first-page":"115485","DOI":"10.1016\/j.diagmicrobio.2021.115485","article-title":"Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes","volume":"101","author":"Quirino","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2022022313004078000_dkab449-B17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkz548","article-title":"The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles","volume":"75","author":"Jonasson","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2022022313004078000_dkab449-B18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/cid\/ciab126","article-title":"Implementation of a rapid phenotypic susceptibility platform for Gram-negative bloodstream infections with paired antimicrobial stewardship intervention: is the juice worth the squeeze?","volume":"73","author":"Robinson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022022313004078000_dkab449-B19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12866-019-1654-9","article-title":"Evaluation of a new rapid antimicrobial susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST","volume":"19","author":"Anton-Vazquez","year":"2019","journal-title":"BMC Microbiol"},{"key":"2022022313004078000_dkab449-B20","first-page":"649.e1\u201310","article-title":"Elaboration of a consensual definition of de-escalation allowing a ranking of \u03b2-lactams","volume":"21","author":"Weiss","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2022022313004078000_dkab449-B21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2022022313004078000_dkab449-B22","author":"Royal College of Physicians","year":"2017"},{"key":"2022022313004078000_dkab449-B23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/647952","article-title":"Antimicrobial susceptibility testing: a review of general principles and contemporary practices","volume":"49","author":"Jorgensen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2022022313004078000_dkab449-B24","doi-asserted-by":"crossref","first-page":"e39\u201346","DOI":"10.1093\/cid\/ciaa528","article-title":"Randomized trial evaluating clinical impact of RAPid IDentification and Susceptibility testing for Gram-Negative bacteremia: RAPIDS-GN","volume":"73","author":"Banerjee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022022313004078000_dkab449-B25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmi.2020.03.038","article-title":"Enhanced antimicrobial stewardship based on rapid phenotypic antimicrobial susceptibility testing for bacteraemia in patients with haematological malignancies: a randomized controlled trial","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022022313004078000_dkab449-B26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/cid\/civ447","article-title":"Randomized trial of rapid multiplex polymerase chain reaction\u2013based blood culture identification and susceptibility testing","volume":"61","author":"Banerjee","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022022313004078000_dkab449-B27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"2022022313004078000_dkab449-B28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/424520","article-title":"Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results","volume":"39","author":"Bouza","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2022022313004078000_dkab449-B29","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis","volume":"31","author":"Garnacho-Montero","year":"2003","journal-title":"Crit Care Med"},{"key":"2022022313004078000_dkab449-B30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jac\/dkm497","article-title":"Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use","volume":"61","author":"Kerremans","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2022022313004078000_dkab449-B31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jinf.2014.05.005","article-title":"Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia","volume":"69","author":"Perez","year":"2014","journal-title":"J Infect"},{"key":"2022022313004078000_dkab449-B32","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s10096-012-1588-8","article-title":"Clinical and economic impact of rapid reporting of bacterial identification and antimicrobial susceptibility results of the most frequently processed specimen types","volume":"31","author":"Galar","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022022313004078000_dkab449-B33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1086\/656248","article-title":"Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results","volume":"31","author":"Parta","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2022022313004078000_dkab449-B34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.diagmicrobio.2015.08.004","article-title":"Multicenter evaluation of the Verigene Gram-negative blood culture nucleic acid test for rapid detection of bacteria and resistance determinants in positive blood cultures","volume":"83","author":"Uno","year":"2015","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/3\/771\/42587287\/dkab449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/3\/771\/42587287\/dkab449.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T16:34:55Z","timestamp":1645634095000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/3\/771\/6470618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,12,20]]},"published-print":{"date-parts":[[2022,2,23]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkab449","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,2]]},"published":{"date-parts":[[2021,12,20]]}}}